1	Novel	novel	_	_	_	_	_	_	_
2	therapies	therapy	_	_	_	_	_	_	_
3	for	for	_	_	_	_	_	_	_
4	inflammatory	inflammatory	_	_	_	_	_	_	_
5	bowel	bowel	_	_	_	_	_	_	_
6	disease	disease	_	_	_	_	_	_	_
7	.	.	_	_	_	_	_	_	_

1	Looking	look	_	_	_	_	_	_	_
2	back	back	_	_	_	_	_	_	_
3	at	at	_	_	_	_	_	_	_
4	successes	success	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	failures	failure	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	newer	new	_	_	_	_	_	_	_
9	approaches	approach	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	treating	treat	_	_	_	_	_	_	_
12	IBD	IBD	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	it	it	_	_	_	_	_	_	_
15	is	be	_	_	_	_	_	_	_
16	tempting–although	tempting–although	_	_	_	_	_	_	_
17	still	still	_	_	_	_	_	_	_
18	difficult–to	difficult–to	_	_	_	_	_	_	_
19	draw	draw	_	_	_	_	_	_	_
20	conclusions	conclusion	_	_	_	_	_	_	_
21	about	about	_	_	_	_	_	_	_
22	pathogenesis	pathogenesis	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	When	when	_	_	_	_	_	_	_
2	a	a	_	_	_	_	_	_	_
3	therapy	therapy	_	_	_	_	_	_	_
4	proves	prove	_	_	_	_	_	_	_
5	effective	effective	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	do	do	_	_	_	_	_	_	_
8	clinicians	clinician	_	_	_	_	_	_	_
9	truly	truly	_	_	_	_	_	_	_
10	know	know	_	_	_	_	_	_	_
11	how	how	_	_	_	_	_	_	_
12	it	it	_	_	_	_	_	_	_
13	works	work	_	_	_	_	_	_	_
14	?	?	_	_	_	_	_	_	_

1	Even	even	_	_	_	_	_	_	_
2	with	with	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	therapy	therapy	_	_	_	_	_	_	_
5	as	as	_	_	_	_	_	_	_
6	specific	specific	_	_	_	_	_	_	_
7	as	as	_	_	_	_	_	_	_
8	anti-TNF	anti-tnf	_	_	_	_	_	_	_
9	antibody	antibody	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	it	it	_	_	_	_	_	_	_
12	is	be	_	_	_	_	_	_	_
13	not	not	_	_	_	_	_	_	_
14	clear	clear	_	_	_	_	_	_	_
15	if	if	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	benefit	benefit	_	_	_	_	_	_	_
18	is	be	_	_	_	_	_	_	_
19	attributable	attributable	_	_	_	_	_	_	_
20	to	to	_	_	_	_	_	_	_
21	simple	simple	_	_	_	_	_	_	_
22	binding	binding	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	clearance	clearance	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
27	or	or	_	_	_	_	_	_	_
28	to	to	_	_	_	_	_	_	_
29	binding	binding	_	_	_	_	_	_	_
30	on	on	_	_	_	_	_	_	_
31	the	the	_	_	_	_	_	_	_
32	cell	cell	_	_	_	_	_	_	_
33	surface	surface	_	_	_	_	_	_	_
34	and	and	_	_	_	_	_	_	_
35	subsequent	subsequent	_	_	_	_	_	_	_
36	deletion	deletion	_	_	_	_	_	_	_
37	of	of	_	_	_	_	_	_	_
38	the	the	_	_	_	_	_	_	_
39	activated	activate	_	_	_	_	_	_	_
40	macrophage	macrophage	_	_	_	_	_	_	_
41	.	.	_	_	_	_	_	_	_

1	When	when	_	_	_	_	_	_	_
2	a	a	_	_	_	_	_	_	_
3	drug	drug	_	_	_	_	_	_	_
4	appears	appear	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	be	be	_	_	_	_	_	_	_
7	less	less	_	_	_	_	_	_	_
8	effective	effective	_	_	_	_	_	_	_
9	than	than	_	_	_	_	_	_	_
10	preclinical	preclinical	_	_	_	_	_	_	_
11	models	model	_	_	_	_	_	_	_
12	suggest	suggest	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	can	can	_	_	_	_	_	_	_
15	failures	failure	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	effectiveness	effectiveness	_	_	_	_	_	_	_
18	from	from	_	_	_	_	_	_	_
19	delivery	delivery	_	_	_	_	_	_	_
20	or	or	_	_	_	_	_	_	_
21	dosing	dosing	_	_	_	_	_	_	_
22	be	be	_	_	_	_	_	_	_
23	differentiated	differentiate	_	_	_	_	_	_	_
24	?	?	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	disappointing	disappointing	_	_	_	_	_	_	_
3	results	result	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	clinical	clinical	_	_	_	_	_	_	_
6	trials	trial	_	_	_	_	_	_	_
7	with	with	_	_	_	_	_	_	_
8	IL-10–so	IL-10–so	_	_	_	_	_	_	_
9	at	at	_	_	_	_	_	_	_
10	odds	odd	_	_	_	_	_	_	_
11	with	with	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	prediction	prediction	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	benefit	benefit	_	_	_	_	_	_	_
16	from	from	_	_	_	_	_	_	_
17	animal	animal	_	_	_	_	_	_	_
18	models–bring	models–bring	_	_	_	_	_	_	_
19	into	into	_	_	_	_	_	_	_
20	question	question	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	validity	validity	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	those	those	_	_	_	_	_	_	_
25	models	model	_	_	_	_	_	_	_
26	as	as	_	_	_	_	_	_	_
27	well	well	_	_	_	_	_	_	_
28	as	as	_	_	_	_	_	_	_
29	the	the	_	_	_	_	_	_	_
30	soundness	soundness	_	_	_	_	_	_	_
31	of	of	_	_	_	_	_	_	_
32	design	design	_	_	_	_	_	_	_
33	of	of	_	_	_	_	_	_	_
34	the	the	_	_	_	_	_	_	_
35	clinical	clinical	_	_	_	_	_	_	_
36	trials	trial	_	_	_	_	_	_	_
37	on	on	_	_	_	_	_	_	_
38	which	which	_	_	_	_	_	_	_
39	efficacy	efficacy	_	_	_	_	_	_	_
40	of	of	_	_	_	_	_	_	_
41	IL-10	IL-10	_	_	_	_	_	_	_
42	is	be	_	_	_	_	_	_	_
43	judged	judge	_	_	_	_	_	_	_
44	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	variability	variability	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	response	response	_	_	_	_	_	_	_
5	even	even	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	most	most	_	_	_	_	_	_	_
9	narrowly	narrowly	_	_	_	_	_	_	_
10	targeted	target	_	_	_	_	_	_	_
11	agents	agent	_	_	_	_	_	_	_
12	suggests	suggest	_	_	_	_	_	_	_
13	that	that	_	_	_	_	_	_	_
14	these	these	_	_	_	_	_	_	_
15	diseases	disease	_	_	_	_	_	_	_
16	are	be	_	_	_	_	_	_	_
17	far	far	_	_	_	_	_	_	_
18	more	more	_	_	_	_	_	_	_
19	heterogeneous	heterogeneous	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	humans	human	_	_	_	_	_	_	_
22	than	than	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	their	their	_	_	_	_	_	_	_
25	murine	murine	_	_	_	_	_	_	_
26	counterparts	counterpart	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Clinicians	Clinician	_	_	_	_	_	_	_
2	are	be	_	_	_	_	_	_	_
3	only	only	_	_	_	_	_	_	_
4	just	just	_	_	_	_	_	_	_
5	beginning	begin	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	recognize	recognize	_	_	_	_	_	_	_
8	subclinical	subclinical	_	_	_	_	_	_	_
9	markers	marker	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	response	response	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	it	it	_	_	_	_	_	_	_
15	may	may	_	_	_	_	_	_	_
16	soon	soon	_	_	_	_	_	_	_
17	be	be	_	_	_	_	_	_	_
18	possible	possible	_	_	_	_	_	_	_
19	to	to	_	_	_	_	_	_	_
20	predict	predict	_	_	_	_	_	_	_
21	response	response	_	_	_	_	_	_	_
22	on	on	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	basis	basis	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	genetic	genetic	_	_	_	_	_	_	_
27	composition	composition	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	For	for	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	moment	moment	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	however	however	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	field	field	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	pharmacogenetics	pharmacogenetic	_	_	_	_	_	_	_
11	is	be	_	_	_	_	_	_	_
12	embryonic	embryonic	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	Challenges	challenge	_	_	_	_	_	_	_
2	in	in	_	_	_	_	_	_	_
3	developing	develop	_	_	_	_	_	_	_
4	new	new	_	_	_	_	_	_	_
5	therapeutic	therapeutic	_	_	_	_	_	_	_
6	strategies	strategy	_	_	_	_	_	_	_
7	include	include	_	_	_	_	_	_	_
8	not	not	_	_	_	_	_	_	_
9	only	only	_	_	_	_	_	_	_
10	identifying	identify	_	_	_	_	_	_	_
11	novel	novel	_	_	_	_	_	_	_
12	agents	agent	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	but	but	_	_	_	_	_	_	_
15	also	also	_	_	_	_	_	_	_
16	improving	improve	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	definitions	definition	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	clinical	clinical	_	_	_	_	_	_	_
21	endpoints	endpoint	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	defining	define	_	_	_	_	_	_	_
24	efficacy	efficacy	_	_	_	_	_	_	_
25	at	at	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	biologic	biologic	_	_	_	_	_	_	_
28	level	level	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	Only	only	_	_	_	_	_	_	_
2	through	through	_	_	_	_	_	_	_
3	considered	consider	_	_	_	_	_	_	_
4	evaluation	evaluation	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	clinical	clinical	_	_	_	_	_	_	_
7	evidence	evidence	_	_	_	_	_	_	_
8	may	may	_	_	_	_	_	_	_
9	clinicians	clinician	_	_	_	_	_	_	_
10	determine	determine	_	_	_	_	_	_	_
11	which	which	_	_	_	_	_	_	_
12	therapies	therapy	_	_	_	_	_	_	_
13	should	should	_	_	_	_	_	_	_
14	remain	remain	_	_	_	_	_	_	_
15	novelties	novelty	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	which	which	_	_	_	_	_	_	_
18	should	should	_	_	_	_	_	_	_
19	become	become	_	_	_	_	_	_	_
20	an	an	_	_	_	_	_	_	_
21	accepted	accept	_	_	_	_	_	_	_
22	part	part	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	armamentarium	armamentarium	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

